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Clinical records and information systems allow for extensive quantities of data to be collected and analysed 
to improve patient care—through improving our understanding of the epidemiology of disease—and 
facilitate the development and evaluation of new health interventions. This is an important resource in the 
development of health systems. Information and its transfer within health systems are key to health service 
reform, research, development, quality and safety for patients. In addition, biomedical research allows the 
identification of people at risk of diseases with a genetic basis.  
The law surrounding privacy, confidentiality and data protection is very important and is a key factor in 
enabling the data that is collected to be used towards those positive ends. With the introduction of legislation 
in Ireland, such as the Health Information Bill, and the value of clinical data and population health datasets 
being increasingly recognised as a key tool to supporting research and innovation in clinical practice, this 
paper aims to review relevant legislation and legal principles and consider the implications of future 
legislation for practice.  
Privacy and Confidentiality Law in Ireland 
(i) Privacy Generally – Common and Constitutional Law 
Privacy law in Ireland is long-recognised through common law principles and is given extra protection 
through its constitutional basis in Art.40.3 of the Constitution which promises to vindicate the personal 
rights of individuals. The courts have interpreted the right to privacy as one of these personal rights and, as a 
result, precedent has developed in Ireland protecting people’s privacy.1 The courts uphold the privacy and 
confidentiality inhering in the patient/doctor relationship unless: 
 the patient consents to confidentiality being waived; 
 the doctor is ordered by a court of law to reveal details of the patient/doctor relationship; 
 there is a threat to a third party; or 
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 it is in the public interest to break confidentiality.2 
Unless any of these criteria are met, the doctor must abide by the Hippocratic Oath which states: “To 
whatever in connection with my professional practice, or not in connection with it, I see or hear, in the life of 
men, which ought not be spoken of abroad, I will not divulge, as reckoning that all should be kept secret.”  
(ii) European Convention on Human Rights 
The European Convention on Human Rights (ECHR) guarantees Irish citizens a right to privacy under art.8. 
Article 8 guarantees that:  
1. Everyone has the right to respect for his private and family life, his home and his correspondence. 
2. There shall be no interference by a public authority with the exercise of this right except such as is 
in accordance with the law and is necessary in a democratic society in the interests of national 
security, public safety or the economic well-being of the country, for the prevention of disorder or 
crime, for the protection of health or morals, or for the protection of the rights and freedoms of 
others.  
The patient has a right to privacy under art.8 of the ECHR and, as a result, the doctor and hospital have a 
duty of confidentiality to ensure the information remains private. The patient/doctor relationship is known as 
a fiduciary relationship and the doctor owes a duty of care in respect of the patient’s personal information 
and health information.  The common law and constitutional principles of privacy, along with the pre-
existing duties of care and confidentiality, are further buttressed by the ECHR.  
(iii) Data Protection 
The law surrounding personal data in Ireland is governed by the Data Protection Acts 1988 and 2003 (the 
“DP Acts”). Patient medical data in Ireland must be protected in accordance with the DP Acts—the Data 
Protection (Amendment) Act 2003 amended the Data Protection Act 1988 in order to transpose the EU data 
protection directive.
3
 The EU data protection directive was an important landmark in regulating the way 
personal data was processed within the EU in the mid-nineties. The DP Acts are very important in protecting 
patients’ information in Ireland and in ensuring third parties cannot have access to patients’ information 
without their express consent. The DP Acts differentiate between “personal data” and “sensitive personal 
data”. Personal data is defined as data “relating to a living individual who is or can be identified either from 
the data or from the data in conjunction with other information that is in, or is likely to come into, the 
possession of the data controller”.4 Sensitive personal data, on the other hand, includes personal data in 
relation to the “physical or mental health condition or sexual life of the data subject”.5  
While the DP Acts contain certain protections for “personal data”, they go further where sensitive personal 
data is concerned.  The latter is governed by s.2B of the Data Protection Act 1998 which provides significant 
safeguards for handling sensitive personal data. A loss of control over an individual’s personal data, 
especially sensitive personal data such as medical data, is seen as a loss of autonomy and has led the courts 
and the Data Protection Commissioner (DPC) to prevent or minimise such a loss of control. For example, in 
Case 11/2012, the DPC opposed a Department of Education circular which required that a teacher’s medical 
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certificate, explaining an absence from school, confirm the nature of the teacher’s illness. The DPC stated 
that “an employer would not normally have a legitimate interest in knowing the precise nature of an illness 
and it would therefore be at risk of breaching the Data Protection Acts if it sought such information”. 6 
Explicit consent is required for the processing of sensitive personal data of a patient/data subject. The GP is 
known as the “data controller” of the information and, as data controller, he is responsible for ensuring that 
the information is protected and safeguarded from others. It is the responsibility of the data controller to 
ensure the confidentiality of patient data and to obtain consent for its future use in research.
7
  
There is an “opt in” and an “opt out” approach in medical research and it is important for patients to be 
aware of the approach in operation in order for them to know whether their information will be used for 
research or not. The “opt in” approach for patients means that they must actively consent to the research in 
order for their data to be included, and the “opt out” approach means they will automatically be included in 
the research unless they tell their GP or the research body that they wish to be excluded.
8
  
The GP as the data controller can “process” the information, which includes collecting, organising, 
obtaining, recording, controlling and destroying the data. Explicit consent is needed in advance from the 
patient if the GP is to use the patient’s data for research purposes without de-identifying the data. The GP, as 
the data controller, may anonymise the data, and once the data subject (human being) is unidentifiable, the 
information can be used for research as it is no longer “sensitive personal data” according to the DP Acts. In 
addition, if the GP processes and anonymises the data, a third party may use the information for research 
purposes without explicit consent. If a patient believes that his data is not being protected or treated 
correctly, the individual may apply to the DPC for an investigation. If the patient does so apply, then, 
pursuant to s.12 of the DP Acts, a “notice requirement” will be served on the data controller (GP) and this 
requires him to furnish all the information he has regarding the patient to the DPC. He must comply and 
provide the DPC with the information required, as a failure to do so is an offence.  
In order to avoid any investigations by the DPC, GPs should therefore obtain “express consent” from their 
patients to using their data (which has not been de-identified or anonymised) for research purposes. For 
consent to be valid, it must be “freely given, specific, and [an] informed indication of [the data subject’s] 
wishes”.9  The DP Acts do not define express consent, but according to the English Mental Capacity Act 
2005, this means that the data subject/patient must: 
 have received sufficient information and been able to understand the information;  
 not be acting under duress;  
 be able to retain the information; and  
 have the ability to weigh up the information and then communicate the decision.10  
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Research and Children  
Consent is more difficult to ascertain when it comes to children and adults lacking decision-making capacity. 
Children are allowed to participate in research on matters that affect them. One parent’s/guardian’s consent 
is sufficient for a child’s participation unless the Research Ethics Committee involved has found the risks to 
be high, and then both parents’/guardians’ consent is needed. Any child over the age of 16 can consent on 
his or her own behalf to partake in a clinical trial.
12
 It is important to explain to the child taking part what 
will be involved and to obtain his or her assent to the research also.
13
 
Healthy children can also be involved in research and may act as a control group; they should be treated in 
the same way as the other participants and risks should be minimal in the absence of any direct benefits to 
them.  
Adults Lacking Decision-making Capacity  
The participation of this group requires Research Ethics Committee approval and the research should only 
occur if the information cannot be acquired from research on adults with decision-making capacity. The 
research must be expected to give a direct benefit to, or help with the treatment of, the participants. Consent 
must be obtained from the legal representative of the participant, and the wishes of the participant must at all 
times be respected according to the English Mental Capacity Act 2005.
14
 
Epidemiological Research  
This is an important way of monitoring the prevalence of conditions in an area. This type of research 
involves huge numbers of patients and it is usually impractical to obtain consent from everyone. Usually, 
patient-identifiable data is not needed for epidemiological research, and so consent is waived by a Research 
Ethics Committee and the access must be supervised by someone who is very aware of confidentiality 
requirements. Where patient information is anonymised but the nature of the illness is very unique (i.e. an 
unusual health condition such as HIV,) and the patient may still be identified from the data, special care and 
consideration needs to be taken to remove the information that renders the patient identifiable.
15
 
Archived Material  
A lot of research can be carried out on material being kept in archives. The contentious nature of this issue 
was recently highlighted in Ireland with the debate surrounding the PKU heel prick test cards that are being 
stored without the consent of parents/guardians of patients in Temple Street Children’s Hospital, Dublin. 
These tests provide considerable information to researchers with regard to the epidemiology and natural 
history of disease. After much debate, it was decided that this information could not be destroyed, and the 
“opt in” approach was changed to an “opt out” approach.16 The Health Service Executive’s National 
Consent Policy
17
 states that in certain circumstances, biological data from individuals can be used for 
research without consent. These circumstances include where the information is anonymised or if no 
potential harm can come to the individual from whom the biological data was obtained. The Irish 
Government, as a result of the “PKU case”, has established a committee to decide what should be done with 
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the test cards in the future.
18
 The test cards are very important for research because they provide a snap-shot 
of conditions of the recent decades and can provide researchers with a lot of information as to trends in Irish 
people’s health during that time.  
In other circumstances, if consent has been obtained for a primary research investigation, then consent will 
be required for a second, separate research project to be undertaken, unless the researchers can get a 
Research Ethics Committee waiver of consent.
19
 It is still questionable on what legal authority a Research 
Ethics Committee can waive consent which may be otherwise be legally required, and this particular area is 
one of uncertainty. 
Deceased Persons  
The DP Acts do not cover information in relation to deceased persons. As a result, in the absence of prior 
consent, the decision whether to donate material for research when someone dies falls to the next-of-kin. In 
the case of a married adult, this would be the spouse; in the case of a child, it would be a parent; and in the 
case of an unmarried adult, the next-of-kin would be a sibling. Guidelines issued by the Irish Medical 
Council have also suggested executors’ consent. Medical data relating to a deceased individual that can be 
linked to a living person may enjoy the protection of the DP Acts. An example of this would be that of a 
deceased female haemophiliac, as that information would indicate that any surviving sons suffered from the 
disease, as it is X-linked.
20
     
Anonymised Data  
Consent is not required under the DP Acts if the information is anonymised. “Irrevocable anonymisation of 
personal data puts it outside data protection requirements as the data can no longer be linked to an individual 
and therefore cannot be considered to be personal data.”21 The responsibility and process of anonymising 
and de-identifying data falls on the data controller. Once the data has been anonymised, it can be transferred 
to a third party for research without the consent of the data subject.  “Where research can be conducted on 
anonymous data, this is the most desirable option as such data is unidentifiable and the Acts do not apply to 
it. Researchers should attempt to ascertain whether it is possible to receive data in this anonymous format.”22  
No Consent Needed  
In certain circumstances, consent is not needed for research, especially if there is a public health emergency 
and the health teams need research done immediately on certain strains of a flu or virus that is spreading 
throughout the population.
23
 Gaining consent prior to research would be too time-consuming and would 
slow down the process.  
Audits 
An audit does not require explicit consent to be obtained, if the audit being carried out is by the clinical audit 
staff which is comprised of those involved in the patient’s care or their support staff.  
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“Clinical audit is designed to improve the quality of care provided to patients generally. Given the 
fundamental role played by clinical audit in patient care, implied consent is normally all that is 
required when the audit could likely be of benefit to that patient.”24 
If the audit is to be carried out by third parties external to the data controller, informed consent will be 
needed. However, informed consent may be considered sufficient if the patient simply has access to a 
brochure or information sheet informing him that his personal data may be used for an external clinical 
audit, and that he has the opportunity to opt out of the audit if he wishes.
25
 
Establishing a National Register in Ireland  
The National Cancer Registry was set up in 1991 by the Department of Health and has been registering 
cancers since 1994. It is exempt from the application of the consent requirements under the DP Acts, and 
this exemption is contained in legislation.
26
 It allows for all cancer diagnoses in Ireland to be recorded on the 
register, and for the epidemiology and statistical trends in different cancers to be researched, analysed, 
reported and published. Patients diagnosed with cancer will be recorded on the register unless they opt out of 
their records being used. Their information is processed and de-identified by the National Cancer Registry 
which acts as the data controller. Information can be released to the patient’s treating physician, but all other 
research purposes must be consented to by the patient before the information is released.  The data is 
collected from laboratories, death certificates, medical records in hospitals, and other registries. National 
Disease Registers are important research opportunities; they affect the public interest as they concern the 
following huge demographic groups:  
“1. Those currently with the disease 
2.   Those who have suffered with the disease 
3. Those who may suffer with the disease in the future.”27   
A study was done recently on Irish attitudes towards using their medical information for research and it was 
found that “overall participants across demographic groups were positively inclined to medical records 
being used in health research”.28 The male participants were more worried about insurance companies and 
employers learning about their medical issues, and the female participants were concerned about information 
being disclosed to others in the community. The study highlighted that most people would like to be 
informed of the use of their data and have an element of control over their data being used, such as a 
periodic requirement of consent. The consensus from the study was that the majority of Irish people would 
be in favour of the idea of their medical data being used for research for the “greater good” of society in 
general.
29
 This is a very positive attitude towards medical research at the moment, and it shows that the 
majority of Irish people understand and accept the importance of access to patients’ medical records in the 
development of treatments for cancer and chronic illnesses.  
Law and Future Research in Ireland  
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The EU data protection directive, implemented by the Data Protection (Amendment) Act 2003 in Ireland, 
was drafted and designed prior to globalisation, cloud computing and social networking, and it is now 
widely accepted that new standards of protection are required. The EU Commission wants to harmonise data 
protection within the European Union by means of the proposed General Data Protection Regulation 
(GDPR),
30
 and it is expected that this will be adopted in 2014, to be effective from 2016.  
While the draft includes medical information as personal data, the primary aim of the GDPR is to extend the 
application of EU data protection provisions to situations where either the data processor, the data controller 
or the data subject is based in the EU. It would therefore apply to organisations outside the EU if they 
processed the personal data of an EU resident. The notice requirements are expanded and must include 
retention time for personal data and contact information for the data controller and the data protection 
officer.  
Privacy by design and by default are also included in art.23—it requires that data protection is designed into 
the development of business processes for products and that services’ privacy settings are set at a high level 
by default. Data protection officers will be obliged to ensure compliance by organisations and all public 
authorities must appoint data protection officers, as must organisations with more than 250 employees. 
Consent to data collection and to the purposes for which it will be used must be explicit (“opt in” now) and 
the consent of minors under 13 must be obtained from their parents. Data controllers must be able to prove 
consent, and consent must be capable of being withdrawn (unless the data is irreversibly anonymised, in 
which case this will not be necessary or possible). Article 17 incorporates a “right to be forgotten” where an 
individual withdraws consent or the data is no longer necessary and there is no legitimate reason for an 
organisation to keep it.  
In Ireland, the Health Information Bill
31
 is due to be enacted in 2014 and will provide the legislation needed 
to allow for patient information to be transferred between public and private sectors in a safe manner and in 
line with the best interests of the patient. It will play a significant role in the health information management 
process, including the collection, use, storage, transfer, disclosure and privacy of personal health 
information. It will remove information-flow obstacles and will assist in new technologies needed for patient 
treatment. It will be the root of a national and system-wide information governance framework for the health 
service in Ireland. The Health Reform Programme in Ireland is the initiative behind the Health Information 
Bill. The Reform Programme wishes to have a health service created whereby patient records can be 
accessed wherever the patient is in the country. There will be a national database, and patients’ health 
summaries will be accessible through this. The Health Information Bill is required for this reform to 
succeed, as the national database will require robust governance. In light of the supremacy of EU law, 
however, the Bill cannot be enacted if it contains any provision conflicting with any adopted EU legislative 
instrument. 
General Practices and Future Research 
Explicit consent will be required from patients in order for the data controller to be able to process 
identifiable patient information for a purpose other than patient treatment. An opt-in approach will be 
applicable. Consent to future use of the information must be explained to the patient. Any subsequent 
conditions the patient develops will require new consent before the information can be used for research. In 
order for a third party to research the information, the data controller must anonymise the data and protect 
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the privacy of the patient; otherwise, express consent must be obtained from the patient allowing the third 
party access to the information.  Internal clinical audits do not require explicit consent; however, the patient 
must have access to information about external clinical audits in the form of a brochure, and the patient must 
know that he can opt out of the audit.
32
 
Law and Practice in England—A Precedent to Follow? 
Patient privacy and confidentiality in England is governed by the Human Rights Act 1998 and the Data 
Protection Act 1998.  
Patient Privacy: ECHR Law 
The Human Rights Act 1998 guarantees everyone a right to respect for their private life, and this includes 
confidentiality regarding medical records.
33
 The Human Rights Act 1998 became applicable in England in 
2000 and implemented the ECHR in England. Article 8 of the ECHR applies in England as in Ireland, and it 
“guarantees a right to respect for private and family life”.34 The patient’s right to privacy over his medical 
records is protected by art.8 of the ECHR and the National Health Service (NHS) acknowledges this 
protection for patients and their medical records.
35
   
Data Protection 
The Data Protection Act 1998 implemented the EU data protection directive in England and it defines 
“personal data” in s.1 and “sensitive personal data” in s.2.  
Personal data means “data which relates to a living individual who can be identified—(a) from [that] data, or 
(b) from [that] data and other information which is in the possession of, or is likely to come into the 
possession of, the data controller ...”.36 
Whereas “sensitive personal data” concerns the subject’s race, ethnicity, politics, religion, trade union status, 
health, sex life or criminal record.
37
 Patient’s health information therefore comes under the definition of 
“sensitive personal data” and is awarded greater protection. Informed consent from patients is required 
before patient records can be disclosed for research.
38
 The terms “data controller”, “processor” and “data 
subject” all have the same interpretation in England as they do in Ireland. If there is any breach in a patient’s 
data protection, the Information Commissioner’s office will investigate the complaint for the patient.39  
Common Law  
Previous court  judgments in England have allowed patient information to remain private and confidential in 
the majority of cases. The case of X v Y
40
 highlighted the importance of patient confidentiality; in that case, 
the court held that the health records of two doctors who had contracted AIDs should not be disclosed in a 
newspaper, despite the public interest in knowing this information.  
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“It is in the public interest that actual or potential AIDS sufferers should be able to resort to hospitals 
without fear of this being revealed, that those owing duties of confidence in their employment should 
be loyal and should not disclose confidential matters and that, prima facie, no one should be allowed 
to use information extracted in breach of confidence from hospital records even if disclosure of the 
particular information may not give rise to immediately apparent harm.”41  
There will be times when a public interest issue, or threat to the life of another individual, require a breach 
of patient confidentiality.
42
 The general principle, however, is that patient information between doctor and 
patient is confidential and should remain so.
43
 However, in the past few years, the NHS has made huge 
changes in its storage and use of patient records. The Prime Minister, David Cameron, stated in 2011 that he 
wished for every NHS patient to be “a research patient with their medical details opened up to private health 
care firms”.44  
Electronic Records  
The NHS is in the process of changing from written records to electronic records, and they are proving to be 
a very effective means of communication in England. Electronic records have allowed the NHS to 
considerably develop its health research databases and, as a result, its overall health system. “The rapid 
digitization of medical records and administrative databases coupled with advances in statistics and 
computing capabilities promise to make epidemiological studies for improving health care more fruitful than 
ever.”45    
Summary Cards  
The NHS, with the help of the Health and Social Care Information Centre (HSCIC), is developing a modern 
information system which will allow for all medical information (from general practices and hospitals) 
regarding a patient to be linked and saved in a secure central system which is managed by the HSCIC (data 
controller). It will provide a summary of patients’ records and will provide medical staff anywhere in 
England access to basic medical details of the patient in order to treat the patient in an emergency. A 
summary card is therefore an electronic record of patients’ medical details and it will improve the quality 
and safety of patient care.
46
 Patients will be asked before medical staff access the information, and if a 
patient wishes to opt out of the summary card, he can tell his GP. This will ensure that records regarding that 
patient do not leave the patient’s GP practice and the patient will not have a summary card; however, 
records regarding that patient in a hospital or other NHS service may still flow into the HSCIC system.
47
 
The HSCIC, as the data controller, has the responsibility of ensuring the information remains confidential, 
and the identifiable information can only be shared with others where: 
1. there is a court order;  
2. there is a threat to the life of a third party;  
3. there is a public interest48; or  
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4. where the patient has consented.49  
If there is a breach of the Data Protection Act 1998, the Information Commissioner will impose heavy fines 
and penalties.
50
 Researchers can carry out studies on summary card data; however, the information will be 
anonymised and unidentifiable. The Confidentiality Advisory Group can allow special approval to 
researchers who require identifiable information if it believes the research is in the public interest and will 
benefit the health service, e.g. research on cancer waiting times and the effect on patient survival.
51
   
Research Networks  
The National Institute for Health Research (NIHR) was set up by the NHS in 2006 by the Department of 
Health. The Clinical Research Network is part of this and its aim is to “create a world class health system 
within the NHS”.52 It provides the resources for clinical studies to be set up quickly and efficiently through 
the provision of funding, informative staff and help in identifying and recruiting suitable patients to 
volunteer their medical information for research purposes. The NIHR distributes £280 million research 
funding per year to primary and secondary care in England.  
Future Research in England  
As previously noted, the Prime Minister hopes to evolve every NHS patient into a “research patient”.53 It is 
hoped that all anonymous data generated within the NHS will be used to make medical breakthroughs and to 
attract extra pharmaceutical companies into England and further develop medical research in England.
54
 
Like Ireland, however, England must comply with the EU GDPR which will be in effect from 2016 and will 
provide tight controls over data protection throughout Europe. All research that occurs in the NHS will have 
to comply with the GDPR’s guidelines, and it will impose strict regulations on access to patient records for 
medical research. Consent to data collection and to the purposes for which it will be used must be explicit 
(opt in) and the consent of minors under 13 must be obtained from their parents. Data controllers must be 
able to prove consent and it must be capable of being withdrawn. As previously stated, art.17 incorporates a 
“right to be forgotten” where an individual withdraws consent or the data is no longer necessary and there is 
no legitimate reason for the organisation to keep it. 
Conclusion 
Consent is the key to research and patient records in Ireland and England; however, if the information is de-
identified and anonymised by the data controller, consent is not needed.  Currently the DP Acts, the 
Constitution, the ECHR and common law provide the bases for privacy and confidentiality in Ireland. The 
DPC is a source of refuge for any patient who believes that his data has been used inappropriately.  
The National Cancer Registry, which is a national research network, has been set up by the Irish 
Government and is exempt from the DP Acts. The advent of national research networks in Ireland and 
England allows for huge amounts of research to be undertaken which is integral to medical advances and the 
development of new information, technology and health services reform. The changeover to electronic 
medical records has been made in England, and with the introduction of the Health Information Bill in 
Ireland, the same transition is expected to occur. The majority of patients in Ireland understand the 
                                                          
49
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http://www.nhs.uk/NHSEngland/thenhs/records/healthrecords/Pages/care-data.aspx [last accessed April 14, 2014]. 
50
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importance of research and the use of population health datasets in the development of medicine for the 
greater good.
55
   
The future surrounding medical records, datasets and research in Ireland and England are, however, subject 
to the implementation and transposition of the GDPR. The GDPR will be in effect from 2016, and will 
govern the use and protection of medical records and population health datasets in Ireland, England and the 
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